http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0439030-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4841
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 1991-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1993-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1993-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0439030-B1
titleOfInvention Oral dosage forms containing pimobendan
abstract Pimobendan dosage forms for oral administration contain citric acid, ensuring constantly good absorption even with large pH variations in the gastrointestinal tract.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102004011512-B4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2783682-A1
priorityDate 1990-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4823
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128822180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID134415188
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415159
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408288

Total number of triples: 28.